Statistics

Total Visits

Views
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors 73
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors 8

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors 1 7 3 0 1 5 4

File Downloads

Views

Top Country Views

Views
United States 30
China 18
Netherlands 8
Vietnam 7
Hong Kong SAR China 2
Singapore 2
Australia 1
France 1

Top City Views

Views
Ashburn 13
Rotterdam 8
Hanoi 7
Zhengzhou 6
Beijing 4
Changchun 3
Fairfield 3
Central 2
Singapore 2
Des Moines 1